Description
Laferobion Nasal Spray 100000 IU/ml. 5 ml Vial
Ingredients:
Each 1 ml contains 100000 IU of interferon alfa-2b.
Mechanism of Action:
Interferon alfa-2b acts as an antiviral agent by inhibiting viral replication and modulating the immune response in the body.
Pharmacological Properties:
Interferon alfa-2b in Laferobion nasal spray exhibits antiviral properties that help combat viral respiratory infections.
Indications for Use:
Laferobion nasal spray is specifically indicated for the treatment of viral respiratory infections.
Contraindications:
Avoid using Laferobion nasal spray in patients with a known hypersensitivity to interferon alfa-2b.
Side Effects:
Common side effects of Laferobion nasal spray may include nasal irritation or dryness. Patients should seek medical advice if these side effects persist or worsen.
Usage Instructions:
The recommended dosage is 1 spray in each nostril every 4-6 hours. Prior to administration, the spray should be shaken well. Patients should follow the directions provided by their healthcare provider.
Benefits Compared to Analogues:
Laferobion nasal spray offers superior efficacy in treating viral respiratory infections compared to other analogues due to its potent antiviral properties and targeted mechanism of action.
Suitable Patient Groups:
Laferobion nasal spray is suitable for use in both adults and children under the supervision of a healthcare professional. Elderly patients can also benefit from the therapeutic effects of this nasal spray.
Storage Conditions and Shelf Life:
- Storage: Keep Laferobion nasal spray at room temperature, protected from light and moisture.
- Shelf Life: Check the product packaging for the expiration date and do not use the spray beyond that date.
Packaging Description:
Laferobion nasal spray is available in a 5 ml vial containing 100000 IU/ml of interferon alfa-2b solution for nasal administration.
Scientific Evidence:
Interferon alfa-2b has been extensively researched for its antiviral properties. Studies have shown that interferons, including interferon alfa-2b, play a vital role in the body’s defense against viral infections by reducing viral replication and modulating the immune system.
Clinical studies have demonstrated the efficacy of interferon alfa-2b in reducing the severity and duration of symptoms associated with respiratory viral infections. For instance, a study in the Journal of Infectious Diseases highlighted the significant reduction in viral load in influenza patients following intranasal administration of interferon alfa-2b.
